CRON FY 2024 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$983M

FY 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$118M+34.8% YoY

Gross Profit

$25M21.4% margin

Operating Income

-$77M-65.1% margin

Net Income

$41M34.9% margin

EPS (Diluted)

$0.11

Cash Flow

Operating Cash Flow

$19M

Free Cash Flow

$6M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$55M

Stockholders' Equity

$1.1B

Cash & Equivalents

$859M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$118M	$87M	+34.8%
Gross Profit	$25M	$12M	+111.6%
Operating Income	-$77M	-$85M	+9.8%
Net Income	$41M	-$74M	+155.5%